S2: Control of Blood Glucose and the Endocrine Pancreas Flashcards

1
Q

What keeps blood glucose kept constant?

A

Blood glucose is kept within constant limits by insulin, despite periodic intake of sugar and bursts of exercise requiring fuels

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the liver’s role in glucose control?

A

The liver sits at the head of the portal vein (taking blood from the gut and feeding it into the liver). The liver has a high capacity to take up glucose and can buffer increases in blood sugar concentration (keep levels constant).

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Describe arrangement of cells in islet of Langehans

A
  • Arrangement of cells in islet of Langehans : clusters of endocrine cells surrounded by exocrine pancreas
  • The islets form only a small part of the pancreatic mass but receive a very large part of the pancreatic blood supply

Cells in islets:

  • Beta cells that release insulin (inside)
  • Alpha cells which release glucagon (outside)
  • Delta cells release somatostatin (GHIH) which inhibits both glucagon and insulin release
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe synthesis of insulin

A

Insulin is a small polypeptide so is encoded for by a gene. The original transcript gives pre-proinsulin.
Pre-proinsulin has the signal sequence cleaved off to give proinsulin (in RER).
Then proinsulin has chain C removed in Golgi apparatus to give insulin
Insulin then packaged into secretory vesicles
One mole of C-peptide is secreted for each mole of insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What stimulates insulin release?

A
  • Rising blood glucose levels
  • Most amino acids can stimulate insulin release (albeit to different extents).
  • As well as non-esterified fatty acids, also called free fatty acids (NEFAs), precise role not clear as of yet.
  • Secretion is also regulated by the autonomic nervous system, through sympathetic and parasympathetic mechanism.

However, insulin release is almost entirely locally regulated (i.e. the beta cells respond to the high glucose in the blood) and a neural input isn’t needed, although it can modulate it.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe insulin release and glucose concentration graph

A

Here we can see release of insulin in relation to blood glucose concentration, from low to very high. The threshold for insulin release is around 5mmol/l of glucose. This means once blood glucose drops below this insulin release shuts down, the anabolic actions of insulin stop and catabolic actions of glucagon take over – preventing blood glucose from falling further. Also note that 50% of insulin reaching the liver is removed in its first passage through.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Describe blood supply of pancreas

A

Pancreas supplied by branches of the coeliac, superior mesenteric, and splenic arteries.
The venous drainage of the pancreas is into the portal system.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Why is insulin in peripheral circulation diluted?

A

Hepatic portal vein is only a fraction of the cardiac output, so insulin levels in the peripheral circulation (where you can easily sample) are much diluted.

Half of the secreted insulin is metabolized by the liver in it’s first pass; the remainder is diluted in the peripheral circulation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Why is C-peptide a more accurate index of insulin secretion in peripheral circulation?

A

C-pepitide is not metabolised by the liver

-One mole of C-peptide is secreted for each mole of insulin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How do the beta cells know blood glucose has risen?

A
  • Indirectly via a response to the end-products of glucose oxidation.
  • The beta-cell membrane has GLUT-2 transporters, so as blood glucose rises in diffuses into cell down its gradient.
  • It enters glycolysis and TCA resulting in increased ATP
  • There is an ATP sensitive K+ channel in membrane
  • ATP acts as an intracellular messenger and closes the channel so there is depolarisation of the membrane (as K+ cannot diffuse out)
  • Voltage gated Ca2+ open which influx and acts as intracellular messengers causing exocytosis of vesicles containing insulin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

List factors regulating insulin secretion

A

Positive:

  • Incretin hormones
  • Plasma glucose
  • Amino acids
  • Parasympathetic nervous system

Negative:

  • Alpha adrenergic
  • Somatostatin
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Why does amino acids stimulate both insulin and glucagon?

A

Not all meals are high carbohydrate, low carb meals and insulin release could lead to hypoglycaemic conditions

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Effects of insulin

A
  • Uptake of glucose into adipose tissue, skeletal muscle and cardiac muscle
  • Uptake of FFAs and amino acids into adipose and muscle tissue
  • Stimulation of glycogen synthesis, inhibition of glycogenolysis
  • Inhibition of gluconeogenesis, lipolysis and proteolysis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Describe signalling at insulin receptor (mechanism and result)

A
  • Effects of insulin come about through insulin binding to its receptor.
  • The insulin receptor is a tyrosine kinase receptor, so when insulin binds tyrosine kinase (present on inside of membrane) is activated (by phosphorylation)
  • This then phosphorylates insulin receptor substrate (IRS) and activation of further downstream cell signalling pathways
  • Many metabolic effects of insulin involve phosphorylation cascade activated by PIP3
  • Growth factor-like effects involve MAPK signaling

As a result:

  • There is insertion of glucose transporter into cell membrane – allowing uptake of glucose down its gradient
  • Glycogen synthesis
  • Gene transcription so modulates activity of metabolic enzymes
  • Activates cascade of protein phosphorylation, which stimulate or inhibit specific metabolic enzymes by modulating enzyme phosphorylation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does glucose get into cells?

A
  1. Sodium glucose cotransporters (SGLTs)
  • Secondary AT
  • SGLT1: glucose absorption from gut
  • SGLT2: glucose reabsorption from kidney (PCT)
  1. Glucose Transporters (GLUT)
    - Affinity of these transporters is the rate glucose can pass through
    - GLUT 2 (liver, kidney, pancreas) is a low affinity transporter. This allows a constant rate of glucose flow over a range of concentration = glucose dependent release
    - GLUT 4 (muscle and adipose tissue) has medium affinity of glucose important for removal of glucose from blood for storage = insulin dependent uptake of glucose
    - Also GLUT 1 (brain, erythrocytes, placenta) and GLUT 3 (brain) – both high affinity for glucose. GLUT 3 has preferential uptake of glucose in hypoglycaemia
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What is the relationship of Km and affinity of GLUT transporters?

A

High Km= Low affinity

17
Q

When is glucagon stimulated?

A

What is important is the ratio of insulin:glucagon, the ratio falls during the fasting state. So there is a drop in insulin causing a drop in the ratio,
Once you drop below 5mmol/l glucose, insulin release will stop so all the processes aiming to store glucose/remove it from the blood will stop and the reverse processes will be favoured, this prevents/limits hypoglycemia. Glucagon release will then also limit hypoglycemia.

18
Q

What are the effects of glucagon?

A

It will stimulate

  • Glycogenolysis
  • Gluconeogenesis
  • Ketogenesis
19
Q

What happens during hypoglycemia?

A

Glucagon is stimulated and released causing glycogenolysis, gluconeogenesis and ketogenesis.

If hypoglycemia persists (moving into starvation state) the sympathetic nervous system could directly cause more release of glucagon in liver and stimulation of catabolic processes in liver and other tissues. Release of fatty acids.
Adrenaline also will be stimulating these processes.

20
Q

List factors regulating glucagon secretion

A

Positive:

  • Amino acids
  • Alpha adrenergic
  • Decrease in plasma glucose
  • Parasympathetic

Negative:

  • Insulin
  • Somatostatin
21
Q

How is glucagon synthesised?

A
  • Glucagon is a peptide so it starts off as pro-glucagon which gets cleaved to glucagon in alpha cells in the pancreas.
  • However, the pro-glucagon gene (that in pancreas leads to glucagon), can be processed differently. In the small intestine it is processed differently to give us a range of different products (glucagon, GLP-1)
22
Q

What are the 3 important gut peptides (incretins)?

A
  1. GIP (pro-gastrointestinal polypeptide). GIPs major effect is to slow the rate of gastric emptying, but it also potentiates insulin’s response to glucose especially when there is very fatty/sugary meal.

From pro-glucagon gene:

  1. Glucagon
  2. GLP-1 (glucagon like peptide 1) which increases insulin secretion
23
Q

Role of 3 incretins

A

They act synergistically (together), their release is stimulated especially in digestion. So they immediately prime the pancreas to be ready to deal with the increase in blood sugar.

24
Q

Mechanism of incretins controlling B cell insulin release

A

GLP-1 and GIP bind to cell surface receptors on the beta cells of the pancreas. Their receptors have AC activity on the inside, leading to increased cAMP which then has a similar effect to ATP (during glucose stimulated insulin release), in that it leads to closure of the potassium channels, causing membrane depolarisation, activation of vgCa2+ channels and hence exocytosis of vesicles containing insulin.

25
Q

How has GLP-1 and GIP lead to new drugs in treating diabetes mellitus?

A

In response to glucose and fats in the intestine we get release of GLP-1 and GIP. These travel via the circulation to the pancreas where they potentiate insulin secretion, allowing blood glucose to swiftly be brought down.
However, these peptides are rapidly degraded by the enzyme DPP-4, so they aren’t in the plasma for long. For this reason we cannot use the peptides themselves for drugs in order to increase insulin release.
So the two strategies are to either
-Find a long acting analogue (synthetic version) of GLP-1
-Or an inhibitor of DPP-4

Both of these strategies work and drugs to this have been developed. Remember this is treatment only for type II diabetes

26
Q

Describe type I diabetes

A

In type I diabetes mellitus is an absolute insulin deficiency due to the beta cells of the islets of Langerhans no longer work and there is no insulin secreted.

Possibly due to genetic susceptibility, environmental factors (virus, dietary) resulting in/or immune (autoimmunity).

So for this reason the treatment (which promotes insulin secretion - GLP-1 and GIP) wouldn’t be much of use because there is no insulin released anyway (nothing for them to potentiate).
- They would be C peptide negative.

27
Q

Describe type II diabetes

A

Type II diabetes mellitus is an insulin insufficiency, so there is a lack of insulin and also a decrease in sensitivity of tissues to insulin.

Possibly due to genetic susceptibility interacting with environmental factors (obesity, poor foetal development) or loss of receptors.

So it can be treated by potentiating insulin’s actions.

28
Q

Blood results and tests to diagnose diabetes

A

Hyperglycemia is central to the diagnosis
• Random plasma glucose ≥ 11.1 mmol L-1
• Fasting plasma glucose ≥ 7.0 mmol L-1
• Oral glucose tolerance test (OGT) ≥ 11.1 mmol L-1
(2 hrs after 75g oral glucose load)

29
Q

Describe ketoacidosis

A

Keto acid formation in the liver: ketoacidosis in type 1 diabetes which occurs when there is a lack of insulin. Insulin inhibits lipolysis.

• Normally ketones (acids) are buffered by the blood
• In insulin deficiency (i.e. type 1 diabetes mellitus) the buffering capacity is overwhelmed
• decreased serum bicarbonate
• diabetic ketoacidosis
deep sighing (Kussmaul) respiration

30
Q

Describe the flow of fuels after a overnight fast

A
  • Glucose released into the circulation
  • Release of free (non-esterfied) fatty acids from adipose tissue, uptake into muscle and formation of ketone bodies in liver and formation of TAG for for recirculation as VLDLs
  • Gluconeogenesis

Actions of glucagon prevail, needed to maintain blood sugars esp. for brain

31
Q

Describe flow of fuels after breakfast

A
  • Glucose taken up into liver, muscle and adipose tissue with formation of glycogen or TAG
  • Amino acids taken up into liver and muscle
  • Lipolysis and proteolysis inhibited
  • Ketogenesis inhibited

Actions of insulin prevail

32
Q

List other hormones that mobilise blood sugar (glucagon like actions)

A
  • Adrenaline
  • Growth Hormone
  • Cortisol
  • Thyroid Hormone
33
Q

What is the glucose tolerance test?

A

Where 75g of glucose is given and then 2hr later blood glucose is measured. If above 11.1 then diabetes. Under normal conditions due to the actions of insulin the glucose will be unable to produce a significant rise.

34
Q

What test is an good indicator of glycaemic control?

A

Glycosylated Hb (A1C) levels are good indicator of glycaemic control

35
Q

Treatment for type 1 diabetes

A

Insulin replacement – Human insulin’s or islet cell transplantation

36
Q

Treatment for type 2 diabetes

A

Insulin secretagogues -> increase insulin secretion, such as GLP-1

Insulin sensitisers
-> Aim of treatment is to control hyperglycemia (maintain normal glucose level) thus reduce diabetic complications and increase life expectancy

37
Q

List complications of diabetes due to poor control of hyperglycaemia

A

Macrovascular changes -> Accelerated atherosclerosis due to the hyperglycemia causing endothelial injury, platelet adhesion and plaque formation

Microvascular changes -> Structural changes in microvasculature leading to retinopathy, neuropathy, nephropathy.